Condition: Cancer · Hearing Loss Ototoxic · Cognitive Decline · Sponsor: Turku University Hospital
The study will assess the effect of cancer treatments on speech perception in noise, cognition, and hearing-related quality of life by monitoring 200 cancer patients receiving standard care for their underlying malignancy.
This description comes directly from the study's public registry record.
Tytti Willberg, PhD · +358 2 313 5979 · tytti.willberg@varha.fi
Always discuss trial participation with your own doctor first.
| Turku University Hospital | Turku, Southwest Finland, Finland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06551857